Categories Navigation

Asset Publisher

null Retrovirus and Zoonoses Research Group
Hospital Universitario Parc Taulí (Barcelona)


The team belows to the Retrovirus and Zoonoses Research Group of the Instituto de Investigación y Innovación Parc Taulí del Hospital Universitario Parc Taulí (HUPT)-UAB.  The team is taking part of the Spanish Research Network on AIDS since the beginning of this Network. It allows to carry out multi-center projects and take part of national and international cohort (CoRIS, COHERE, ART-CC, HIV-CASUAL), and with international groups from around the world

The research lines in which we are currently working are:

  • HIV in elderly patients. Study of the epidemiological clinical characteristics of elderly HIV + patients comparing them with young patients and normal population. The population of elderly HIV-infected persons was increasing and presented differential clinical and epidemiological characteristics that, to a certain extent, were explained by the diagnostic delay observed in this age group. Special emphasis was placed on the need to raise awareness among health personnel in order to avoid this diagnostic delay. Continuing in this group of patients we have been interested in the early diagnosis, the study of cell aging and the fragility of this group.

  • Neuropsychological alterations in HIV patients coinfected with hepatitis C virus, brain damage in HIV patients. Neuropsychological alterations in patients chronically infected with the hepatitis C virus and observation of changes after curative treatment with direct antiviral agents.

  • HIV and coinfection with hepatitis C virus, patients treated with new hepatitis C drugs, evolution and clinical epidemiological characteristics

  • Clinical epidemiological follow-up of HIV / AIDS infection with participation in the Spanish CoRIS cohort and in the Catalan PISCIS cohort.

Related Assets


Gemma Navarro
Mª José Amengual
Manel Cervantes
Marta Navarro
Sonia Calzado

Related Assets

Related Assets


  • El tratamiento con sustitutivos opiáceos y el consumo ocasional de drogas no comprometen la eficacia del tratamiento de la hepatitis C con pautas libres de interferón en coinfectados por VIH y VHC. 
    Navarro M, Sala M, López S, Font B, Gasch O, Falgueras L, et al.  Rev Enf Emerg 2017; 16: 18-22 
  • Transmitted drug resistance to rilpivirine in newly diagnosed antirretroviral naive adults 
    Alvarez M, Monge S, Chueca N, Guillot V, Viciana P, Anta L, Rodríguez C, Gomez-Sirvent JL, Navarro G, Santos L, Mateo S, García F, CoRIS.  Clin Microbiol Infect 2015, 104: e1-5 doi: 10.1016/j.cmi.2014.08.005. PMID: 25636936. Original article. IF: 9,41 
  • The continiuum of HIV care in Catalonia. 
    Campbell CN, Ambriosioni J, Miró JM; Esteve A, Casabona J, Navarro G, García I, Ferrer E, Force L, Tural C.  AIDS Care 2015; 27: 1449-1454 PMID: 26605781. Original article. IF: 3,57 
  • Serosurvey of Rickettsia typhi and Rickettsia felis in HIV infected patients. 
    Nogueras MM, Pons I, Sanfeliu I, Sala M, Segura F.  Microbiol Immunol 2014; 58: 257-259. PMID: 24467705. Original article. IF: 1,30 
  • Risk of clinically significant depression in HIV-infected patients: effect of antiretroviral drugs. 
    Gutierrez F, García L, Padilla S, Alvarez M, Moreno S, Navarro G, Gomez-Sirvent J, Vidal F, Asensi V, Massià M, CoRIS.  HIV Med 2014; 15: 213-223. PMID: 24215356. Original article. IF: 3,45 
  • Optimal timing for initiation of highly active antiretroviral theraphy in treatment-naïve human immunodeficiency vírus-l-infected individuals presenting with AIDS-defining diseases: the experience of the PISCIS Cohort. 
    Manzardo C, Esteve A, Ortega N, Podzamczer D, Murillas J, Segura F, et al.  Clin Microbiol Infect 2013; 19: 646-653. PMID: 22967234. Original article. IF: 9,41 
  • Persistence of novel first-line antiretroviral regimes in a cohort of HIV positive subjects, CoRIS 2008-2010. 
    Jarrin I, Hernandez B, Alejos B, Riera M, Navarro G, Bernardino JI, CoRIS.  Antiviral Therapy 2013; 18: 161-170. PMID: 22997147. Original article . IF: 3,16. Times cited:6 
  • Disseminated infection by Mycobacterium sherrisii and Histoplasma capsulatum in an African HIV-infected patient. 
    Tajan J, Espasa M, Sala M, Navarro M, Font B, Gonzalez-Martin J, Segura F.  Am J Trop Med HYg 2013; 88: 914-917. PMID: 23419367. Original article. IF: 2,73. Times cited: 1 
  • Identification of recent HIV-1 infection among newly diagnosed cases in Catalonia, Spain (2006-2008). 
    Romero A, Gonzalez V, esteve A, Martró E, Matas L, Tural C, Pumarola T, Casanova A, Ferrer E, Caballero E, Ribera E, Margall N, Domingo P, Farré J, Puig T, Sauca MG, Barrufet P, Amengual MJ, Navarro G, Navarro M, Vilaró J, AERI Study Group.  Eur J Public health 2012; 22: 802-808. PMID: 22158995. Original article. IF: 2,45. Times cited: 1 
  • Diagnóstico precoz de la infección por VIH. 
    Segura F, Chapinal O, Nogueras MM, Navarro G.  Enfermedades Infecciosas y Microbiologia Clínica 2012; 30:215. PMID: 22342957. Original article. IF: 1,49 

Related Assets